Stocktoria
DNA X, Inc. SONM
Nasdaq · XNAS · stock · Telephone & Telegraph Apparatus · website · IPO 2019-05-10
DNA X, Inc. statistics & valuation
Market cap$8.5M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | — | 17.0% | 20.6% | 16.6% | 11.8% |
| Operating margin | — | -5.3% | 0.5% | -20.5% | -69.6% |
| Net margin | — | -57.7% | -0.1% | -20.2% | -70.8% |
| FCF margin | — | -14.9% | -4.4% | -17.7% | -70.6% |
| Return on assets | -47.1% | -84.7% | -0.2% | -26.2% | -94.0% |
| Return on equity | 259.7% | 590.3% | -0.4% | -70.3% | -207.3% |
| Debt / equity | -0.64× | — | — | — | 0.00× |
| Current ratio | 0.57 | 0.74 | 1.36 | 1.36 | 1.70 |
| Revenue growth | — | -37.7% | 34.1% | 28.0% | -14.7% |
Source: SEC EDGAR filings · CIK 0001178697 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.